Growth Metrics

Varex Imaging (VREX) EBIAT (2016 - 2026)

Varex Imaging has reported EBIAT over the past 11 years, most recently at $2.4 million for Q1 2026.

  • Quarterly EBIAT rose 2500.0% to $2.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$67.2 million through Jan 2026, down 39.71% year-over-year, with the annual reading at -$69.9 million for FY2025, 44.72% down from the prior year.
  • EBIAT was $2.4 million for Q1 2026 at Varex Imaging, down from $12.6 million in the prior quarter.
  • Over five years, EBIAT peaked at $30.7 million in Q3 2023 and troughed at -$89.1 million in Q3 2025.
  • The 5-year median for EBIAT is $3.8 million (2022), against an average of -$2.4 million.
  • Year-over-year, EBIAT plummeted 6464.29% in 2025 and then soared 2500.0% in 2026.
  • A 5-year view of EBIAT shows it stood at $3.2 million in 2022, then plummeted by 115.62% to -$500000.0 in 2023, then tumbled by 10100.0% to -$51.0 million in 2024, then skyrocketed by 124.71% to $12.6 million in 2025, then plummeted by 80.95% to $2.4 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's EBIAT are $2.4 million (Q1 2026), $12.6 million (Q4 2025), and -$89.1 million (Q3 2025).